Atypical presentation is dominant and typical for coeliac disease

Journal of Gastrointestinal and Liver Diseases

Volumn 18, Issue 3, 2009, Pages 285-291

  Nejad, Mohammad Rostami ^a   Rostami, Kamran ^b   Pourhoseingholi, Mohamad Amin ^a   Mojarad, Ehsan Nazemalhosseini ^a   Habibi, Manijeh ^a   Dabiri, Hossein ^a   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anti tissue transglutaminase; Atypical presentation; Coeliac disease; Dyspepsia; Prevalence; Serology

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; MALE; PREVALENCE; PRIMARY MEDICAL CARE; SEROLOGY; ADOLESCENT; AGED; BLOOD; CROSS-SECTIONAL STUDY; IMMUNOLOGY; MIDDLE AGED; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; CELIAC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IGA DEFICIENCY; IMMUNOGLOBULIN G; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; TRANSGLUTAMINASES;

EID: 73949115356     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006; 131: 1981-2002.
2. Rostami K, Malekzadeh R, Shahbazkhani B, Akbari MR, Catassi C. Coeliac disease in Middle Eastern countries: a challenge for the evolutionary history of this complex disorder? Dig Liver Dis 2004; 36: 694-697.
3. de Freitas IN, Sipahi AM, Damiao AO, et al. Celiac disease in Brazilian adults. J Clin Gastroenterol 2002; 34: 430-434.
4. Pereira MA, Ortiz-Agostinho CL, Nishitokukado I, et al. Prevalence of celiac disease in an urban area of Brazil with predominantly European ancestry. World J Gastroenterol 2006; 12: 6546-5650.
5. Rashtak S, Murray JA. Tailored testing for celiac disease. Ann Intern Med 2007; 147: 339-341.
6. Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr Opin Gastroenterol 2007; 23: 142-148.
7. Shahbazkhani B, Forootan M, Merat S, et al. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 231-235.
8. Ludvigsson JF, Askling J, Ekbom A, Montgomery SM. Diagnosis underlying appendectomy and coeliac disease risk. Dig Liver Dis 2006; 38: 823-828.
9. Brar P, Kwon GY, Egbuna, II, et al. Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis 2007; 39: 26-29.
10. Ozaslan E, Akkorlu S, Eskioglu E, Kayhan B. Prevalence of silent celiac disease in patients with dyspepsia. Dig Dis Sci 2007; 52: 692-697.
11. Waldo RT. Iron-deficiency anemia due to silent celiac sprue. Proc (Bayl Univ Med Cent) 2002; 15: 16-17.
12. Shamir R, Eliakim R, Lahat N, Sobel E, Lerner A. ELISA of antiendomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti-endomysial antibodies and tissue transglutaminase antibodies. Isr Med Assoc J 2002; 4: 594-596.
13. Catassi C. Where is celiac disease coming from and why? J Pediatr Gastroenterol Nutr 2005; 40: 279-282.
14. Collin P, Hallstrom O, Maki M, Viander M, Keyrilainen O. Atypical coeliac disease found with serologic screening. Scand J Gastroenterol 1990; 25: 245-250.
15. Dickey W, Stewart F, Nelson J, McBreen G, McMillan SA, Porter KG. Screening for coeliac disease as a possible maternal risk factor for neural tube defect. Clin Genet 1996; 49: 107-108.
16. Fanciulli G, Tomasi PA, Caucci F, Lai E, Sanciu F, Delitala G. Screening for celiac disease in patients with autoimmune thyroid disease: from research studies to daily clinical practice. Ann Ital Med Int 2005; 20: 39-44.
17. Fernandez-Banares F, Esteve-Comas M, Rosinach M. Screening for celiac disease in high risk groups. Gastroenterol Hepatol 2005; 28: 561-566.
18. Goldberg D, Kryszak D, Fasano A, Green PH. Screening for celiac disease in family members: is follow-up testing necessary? Dig Dis Sci 2007; 52: 1082-1086.
19. Mahmud FH, Murray JA, Kudva YC, et al. Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc 2005; 80: 1429-1434.
20. Kawatu D, LeLeiko NS. Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma. Pediatrics 2006; 118: 816-817.
21. Berti I, Della Vedova R, Paduano R, et al. Coeliac disease in primary care: evaluation of a case-finding strategy. Dig Liver Dis 2006; 38: 461-467.
22. Lanzini A, Villanacci V, Apillan N, et al. Epidemiological, clinical and histopathologic characteristics of celiac disease: results of a case-finding population-based program in an Italian community. Scand J Gastroenterol 2005; 40: 950-957.
23. Catassi C, Kryszak D, Louis-Jacques O, et al. Detection of Celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol 2007; 102: 1454-1460.
24. McGough N, Cummings JH. Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye. Proc Nutr Soc 2005; 64: 434-450.
25. Green PH. Where are all those patients with Celiac disease? Am J Gastroenterol 2007; 102: 1461-1463.
26. Vilppula A, Collin P, Maki M, et al. Undetected coeliac disease in the elderly: a biopsy-proven population-based study. Dig Liver Dis 2008; 40: 809-813.
27. Rostami K, Kerckhaert JP6, Tiemessen R, Meijer JW, Mulder CJ. The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate. Eur J Gastroenterol Hepatol 1999; 11: 439-442.
28. Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 2000; 35: 181-183.
29. Tursi A, Brandimarte G, Giorgetti G, Gigliobianco A, Lombardi D, Gasbarrini G. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease. Am J Gastroenterol 2001; 96: 1507-1510.
30. Abrams JA, Diamond B, Rotterdam H, Green PH. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 2004; 49: 546-550.
31. Rostami K, Steegers EA, Wong WY, Braat DD, Steegers-Theunissen RP. Coeliac disease and reproductive disorders: a neglected association. Eur J Obstet Gynecol Reprod Biol 2001; 96: 146-149.
32. Nelson M, Mendoza N, McGough N. A survey of provision of dietetic services for coeliac disease in the UK. J Hum Nutr Diet 2007; 20: 403-411.
33. Tiboni GM, de Vita MG, Faricelli R, Giampietro F, Liberati M. Serological testing for celiac disease in women undergoing assisted reproduction techniques. Hum Reprod 2006; 21: 376-379.
34. Bermejo Velasco PE, Burgos Garcia A. Neurological complications of celiac disease. Med Clin (Barc) 2006; 127: 500-507.
35. Briani C, Zara G, Toffanin E, et al. Neurological complications of celiac disease and autoimmune mechanisms: preliminary data of a prospective study in adult patients. Ann N Y Acad Sci 2005; 1051: 148-155.
36. Kumar V, Rajadhyaksha M, Wortsman J. Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol 2001; 8: 678-685.
37. Li Voon Chong JS, Leong KS, Wallymahmed M, Sturgess R, MacFarlane IA. Is coeliac disease more prevalent in young adults with coexisting Type 1 diabetes mellitus and autoimmune thyroid disease compared with those with Type 1 diabetes mellitus alone? Diabet Med 2002; 19: 334-337.
38. Meize-Grochowski R. Celiac disease: a multisystem autoimmune disorder. Gastroenterol Nurs 2005; 28: 394-402.
39. Slate J, Hookman P, Barkin JS, Phillips RS. Systemic autoimmune disorders associated with celiac disease. Dig Dis Sci 2005; 50: 1705-1707.
40. Troncone R, Greco L, Mayer M, et al. Latent and potential coeliac disease. Acta Paediatr Suppl 1996; 412: 10-14.
41. Murray JA, Rubio-Tapia A, Van Dyke CT, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol 2008; 6: 186-193.
42. Ciclitira PJ. Does clinical presentation correlate with degree of villous atrophy in patients with celiac disease? Nat Clin Pract Gastroenterol Hepatol 2007; 4: 482-483.
43. Sullivan PB, Marsh MN. Small intestinal mucosal histology in the syndrome of persistent diarrhoea and malnutrition: a review. Acta Paediatr Suppl 1992; 381: 72-77.
44. Carroccio A, Campisi G, Iacono G, et al. Oral mucosa of coeliac disease patients produces antiendomysial and antitransglutaminase antibodies: the diagnostic usefulness of an in vitro culture system. Aliment Pharmacol Ther 2007; 25: 1471-1477.
45. Savilahti E, Reunala T, Maki M. Increase of lymphocytes bearing the gamma/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis. Gut 1992; 33: 206-211.
46. Verbeek WH, von Blomberg BM, Scholten PE, Kuik DJ, Mulder CJ, Schreurs MW. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease. Am J Gastroenterol. 2008; 103: 3152-3158.
47. Sbarbati A, Valletta E, Bertini M, et al. Gluten sensitivity and 'normal' histology: is the intestinal mucosa really normal? Dig Liver Dis 2003; 35: 768-773.
48. Freeman HJ. Pearls and pitfalls in the diagnosis of adult celiac disease. Can J Gastroenterol 2008; 22: 273-280.
49. Arentz-Hansen H, McAdam SN, Molberg O, et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002; 123: 803-809.
50. Rostami K. From microenteropathy to villous atrophy: what is treatable? Dig Liver Dis 2003; 35: 758-759.
51. Santaolalla R, Fernandez-Banares F, Rodriguez R, et al. Diagnostic value of duodenal antitissue transglutaminase antibodies in glutensensitive enteropathy. Aliment Pharmacol Ther 2008; 27: 820-829.
52. Paparo F, Petrone E, Tosco A, et al. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am J Gastroenterol 2005; 100: 2294-2298.
53. Rostami K, Villanacci V. Microscopic enteritis: novel prospect in coeliac disease clinical and immuno-histogenesis. Evolution in diagnostic and treatment strategies. Dig Liver Dis 2009; 41: 245-252.
54. Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 2004; 126: 1721-1732.
55. Mein SM, Ladabaum U. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a costeffectiveness analysis. Aliment Pharmacol Ther 2004; 19: 1199-1210.
56. Sanders DS, Patel D, Stephenson TJ, et al. A primary care crosssectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 2003; 15: 407-413.
57. Rostami K, Kerckhaert J, von Blomberg BM, Meijer JW, Wahab P, Mulder CJ. SAT and serology in adult coeliacs, seronegative coeliac disease seems a reality. Neth J Med 1998; 53: 15-19.
58. Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 2007; 147: 294-302.
59. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001; 358: 1504-1508.